9 June 2025 - New drug submission filed by Lipocine's licensing partner Verity Pharma. ...
26 May 2025 - GSK has submitted a new drug submission to Health Canada for depemokimab for two proposed indications: the ...
2 May 2025 - Today, Novo Nordisk Canada announced that Health Canada has accepted for review, under the priority review policy, ...
8 April 2025 - Catalyst Pharmaceuticals today reported that its sub-licensee in Canada, Kye Pharmaceuticals has announced that Health Canada has ...
6 March 2025 - A novel first in class microbiome restoration therapy for the prevention of recurrence of C. difficile infection. ...
13 February 2025 - Fabhalta is the first oral monotherapy for previously treated and treatment naïve adults with paroxysmal nocturnal haemoglobinuria. ...
16 December 2024 - Knight Therapeutics announced today that Knight's new drug submission for Qelbree (viloxazine extended-release capsules) has been accepted ...
2 December 2024 - Esperion today announced that it has filed new drug submissions to Health Canada for Nexletol and Nexlizet, ...
30 September 2024 - Patient special access program continues during Health Canada review. ...
26 September 2024 - Vertex Pharmaceuticals today announced that Health Canada has accepted for review its new drug submission for ...
18 September 2024 - To potentially include adolescents and antibody persistence up to two years. ...
17 September 2024 - If approved, omaveloxolone would be the only disease specific treatment option for patients living with this progressive ...
30 July 2024 - Marius Pharmaceuticals is pleased to announce the submission of its new drug submission for Kyzatrex (testosterone ...
2 July 2024 - Vanza triple granted priority review with a PDUFA target action date of 2 January 2025. ...
2 July 2024 - Novavax's filing is aligned with NACI, US. FDA, EMA and WHO recommendations on vaccine composition. ...